UroGen Pharma Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%), etc.
烏龍製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%)等
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。